159 related articles for article (PubMed ID: 24652076)
1. Relation between BMD and biochemical, transfusion and endocrinological parameters in pediatric thalassemic patients.
Mohseni F; Mohajeri-Tehrani MR; Larijani B; Hamidi Z
Arch Osteoporos; 2014; 9():174. PubMed ID: 24652076
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
Moayeri H; Oloomi Z
Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
[TBL] [Abstract][Full Text] [Related]
3. Changes of bone density in pediatric patients with β-thalassemia major after allogenic hematopoietic stem cell transplantation.
Hamidieh AA; Hamidi Z; Nedaeifard L; Heshmat R; Alimoghaddam K; Larijani B; Ghavamzadeh A; Mohajeri-Tehrani MR
Arch Iran Med; 2013 Feb; 16(2):88-92. PubMed ID: 23360630
[TBL] [Abstract][Full Text] [Related]
4. Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major.
Baldini M; Forti S; Marcon A; Ulivieri FM; Orsatti A; Tampieri B; Airaghi L; Zanaboni L; Cappellini MD
Ann Hematol; 2010 Dec; 89(12):1207-13. PubMed ID: 20582415
[TBL] [Abstract][Full Text] [Related]
5. Bone health evaluation of children and adolescents with homozygous β-thalassemia: implications for practice.
Doulgeraki A; Athanasopoulou H; Voskaki I; Tzagaraki A; Karabatsos F; Fragodimitri C; Georgakopoulou E; Iousef J; Monopolis I; Chatziliami A; Karagiorga M
J Pediatr Hematol Oncol; 2012 Jul; 34(5):344-8. PubMed ID: 22395221
[TBL] [Abstract][Full Text] [Related]
6. How Age, Sex and Transfusion Affects the Incidence of Endocrine and Bone Density Disorders in Major Thalassemic Patients.
Mohajeri-Tehrani MR; Alemzadeh SA; Marzbali FA; Nasserisina S; Hosnan F; Naghghash A; Hamidieh AA; Behfar M; Mohseni F; Rashidian H; Shirazi S; Aboee-Rad M; Qorbani M; Larijani B; Hamidi Z
Iran J Public Health; 2024 Feb; 53(2):433-442. PubMed ID: 38894828
[TBL] [Abstract][Full Text] [Related]
7. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
[TBL] [Abstract][Full Text] [Related]
8. Correlation between criteria of diagnosis of low bone mineral density in adult and pediatric thalassemic patients: a prospective study.
Mohseni F; Mohajeri-Tehrani MR; Larijani B; Hamidi Z
Minerva Pediatr; 2018 Jun; 70(3):246-251. PubMed ID: 26583453
[TBL] [Abstract][Full Text] [Related]
9. Low bone mineral density in adolescents with beta-thalassemia.
Vogiatzi MG; Autio KA; Mait JE; Schneider R; Lesser M; Giardina PJ
Ann N Y Acad Sci; 2005; 1054():462-6. PubMed ID: 16339698
[TBL] [Abstract][Full Text] [Related]
10. Short-term Assessment of HSCT Effects on the Hypothalamus-Pituitary Axis in Pediatric Thalassemic Patients.
Hamidieh AA; Mohseni F; Behfar M; Hamidi Z; Alimoghaddam K; Pajouhi M; Larijani B; Mohajeri-Tehrani MR; Ghavamzadeh A
Arch Iran Med; 2018 Feb; 21(2):56-60. PubMed ID: 29664655
[TBL] [Abstract][Full Text] [Related]
11. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
Zgliczynski W; Kochman M; Misiorowski W; Zdunowski P
Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
[TBL] [Abstract][Full Text] [Related]
12. The impact of genotype on endocrine complications in thalassaemia major.
Skordis N; Michaelidou M; Savva SC; Ioannou Y; Rousounides A; Kleanthous M; Skordos G; Christou S
Eur J Haematol; 2006 Aug; 77(2):150-6. PubMed ID: 16800840
[TBL] [Abstract][Full Text] [Related]
13. Growth and management of short stature in thalassaemia major.
Theodoridis C; Ladis V; Papatheodorou A; Berdousi H; Palamidou F; Evagelopoulou C; Athanassaki K; Konstantoura O; Kattamis C
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():835-44. PubMed ID: 10091154
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density in beta-thalassemia major and intermedia.
Karimi M; Ghiam AF; Hashemi A; Alinejad S; Soweid M; Kashef S
Indian Pediatr; 2007 Jan; 44(1):29-32. PubMed ID: 17277428
[TBL] [Abstract][Full Text] [Related]
15. A cross-sectional study of metabolic and endocrine complications in beta-thalassemia major.
Najafipour F; Aliasgarzadeh A; Aghamohamadzadeh N; Bahrami A; Mobasri M; Niafar M; Khoshbaten M
Ann Saudi Med; 2008; 28(5):361-6. PubMed ID: 18779644
[TBL] [Abstract][Full Text] [Related]
16. Endocrinopathies in Turkish children with Beta thalassemia major: results from a single center study.
Isik P; Yarali N; Tavil B; Demirel F; Karacam GB; Sac RU; Fettah A; Ozkasap S; Kara A; Tunc B
Pediatr Hematol Oncol; 2014 Oct; 31(7):607-15. PubMed ID: 24854890
[TBL] [Abstract][Full Text] [Related]
17. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major.
Casale M; Citarella S; Filosa A; De Michele E; Palmieri F; Ragozzino A; Amendola G; Pugliese U; Tartaglione I; Della Rocca F; Cinque P; Nobili B; Perrotta S
Am J Hematol; 2014 Dec; 89(12):1102-6. PubMed ID: 25197009
[TBL] [Abstract][Full Text] [Related]
18. Thalassemia bone disease: a 19-year longitudinal analysis.
Wong P; Fuller PJ; Gillespie MT; Kartsogiannis V; Kerr PG; Doery JC; Paul E; Bowden DK; Strauss BJ; Milat F
J Bone Miner Res; 2014 Nov; 29(11):2468-73. PubMed ID: 24764138
[TBL] [Abstract][Full Text] [Related]
19. Osteoprotegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia major.
Pietrapertosa AC; Minenna G; Colella SM; Santeramo TM; Renni R; D'Amore M
Panminerva Med; 2009 Mar; 51(1):17-23. PubMed ID: 19352306
[TBL] [Abstract][Full Text] [Related]
20. Assessment of thyroid functions and its role in body growth in thalassemia major.
Jain M; Sinha RS; Chellani H; Anand NK
Indian Pediatr; 1995 Feb; 32(2):213-9. PubMed ID: 8635784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
